HeadaTerm
HeadaTerm 2 Migraine Headache Relief Device
HeadaTerm 2 Migraine Headache Relief Device
Couldn't load pickup availability
HeadaTerm 2 is a clinically proven, safe, and effective medical device worn on users’ foreheads that uses none-invasive neuronal electrical stimulation technology to prevent and treat primary headache, including migraine, tension headache, cluster headache.
✅ FDA OTC approved for migraine relief.
✅ Rechargeable for repeated use.
✅ Manual adjustment for personalized stimulation.
PRE-SALE - Ships from manufacturer's warehouse on May 25th.
Exclusive Pre-sale for HeadaTerm 2!
Act fast! Only 30 pre-sale slots available – reserve yours now!
Pre-sale Discount Code: PREHT30
eTNS Technology
The Most Affordable FDA Cleared Innovative OTC Anti-Migraine Device
Success Rate
HeadaTerm 2 delivers targeted electrical impulses to increase the user's pain tolerance.
* Data source based on over 1000 user tests
Up to 27% more effective than oral medicine
Published by Emergency Medicine in the United States
Learn More
| Brand | HeadaTerm |
|---|---|
| Rechargeable | |
| Principle | eTNS technology |
| Designer | Canada |
| Indications | The TENS device-HeadaTerm 2 is indicated for the prophylactic treatment of episodic migraine in patients 18 years of age or older. |
| Certificate | FDA, CE, TGA, HC, ISO |
For every HeadaTerm 2 Anti-migraine Device purchased, $1 will be donated to VHA Headache Centers
*Donate every 5 months and publish the donation voucher
Learn moreGuarantee
100% secure checkout
30 Days Money Back Guarantee
1-year warranty guarantee
Worldwide Shipping
Fast delivery available
Free Shipping on All Orders Over $30
Multi-country transfer within 5-7 days
Portable
100% Drug-Free
Easy Operation
Quick Effect
New Generation Of Targeted Thrapeutic Anti-Migraine Device
Primary headaches are debilitating conditions that are extremely common among people. Drug treatments are the popular solutions for many patients, but just like with anti-nausea drugs, there are side effects that often turn people away. HeadaTerm offers a drug-free treatment without any side effects.
More advanced than HeadaTerm Generation 1.
How to use
Learn moreOne-button control
- The one-button control feature simplifies the operation of the device, allowing users to easily toggle the on/off switch and adjust the intensity of the nine electric stimulation gears using a single button on the main unit.
Compact And Easy To Carry
- The standard package contains the device main body, 3 pieces of electrodes, a storage bag, a charging cable, a manual, and auxiliary straps.
HeadaTerm 2 Electrode (3-pack)
HOW IT WORKS
Primary headaches, such as migraine, are transmitted by the supraorbital nerve and the supratrochlear nerve. HeadaTerm introduces precise electric impulses from the user’s forehead to act on these nerves and reduce the migraine signals transmitted. The device avoids any drug effects, making it appropriate a wide range of users.
HeadaTerm Official Sustainability Plan
Every 5 used devices can be exchanged for 1 new device.
Learn MoreEmeTerm® HeadaTerm Testimonials
Customers Testimonials
Reference
- Hokenek N M, Erdogan M O, Hokenek U D, et al. Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: A randomize controlled trial[J]. The American Journal of Emergency Medicine, 2021, 39: 80-85.
- Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain. 2003 Apr;4(3):109-21.
- Shealy CN. Transcutaneous electrical nerve stimulation: the treatment of choice for pain and depression. J Altern Complement Med. 2003 Oct;9(5):619-23.
- Huang W, Kutner N, Bliwise DL. Autonomic activation in insomnia: the case for acupuncture. J Clin Sleep Med. 2011 Feb 15;7(1):95-102.
- Kirsch DL, Nichols F. Cranial electrotherapy stimulation for treatment of anxiety, depression, and insomnia. Psychiatr Clin North Am. 2013 Mar;36(1):169-76.
- Schoenen J, Vandersmissen B, Jeangette S, et al. Migraine prevention with a supraorbital transcutaneous stimulator: a randomized controlled trial. Neurology. 2013 Feb 19;80(8):697-704.
- Nihat M. Hokenek, MD. Treatment of migraine attacks by transcutaneous electrical nerve stimulation in emergency department: A randomized controlled trial. VOLUME 39, P80-85, JANUARY 01, 2021